$0.8038
0.00530.66%
At close: Aug 21, 5:00 PM EST
$0.8089
0.00510.63%
After Hours: Aug 21, 7:46 PM EST
BioXcel Therapeutics (BTAI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.51 | $-0.52 | $-1.42 |
| Actual | $-0.49 | $-0.54 | $-0.58 | $-2.18 |
| Surprise | +12.5% | -5.88% | -11.5% | -53.5% |
| Revenue | ||||
| Estimate | $215408 | $363192 | $142912 | $190002 |
| Actual | $182000 | $206000 | $256000 | $98000 |
| Surprise | -15.5% | -43.3% | +79.1% | -48.4% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.94 | $-0.64 | $-0.31 | $-0.29 |
| Revenue | ||||
| Consensus | $233112 | $258416 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.49 | $-0.56 | 12.5 % |
| Q1 | May 15, 2026 | $-0.54 | $-0.51 | -5.88 % |
| Q4 | Mar 27, 2026 | $-0.58 | $-0.52 | -11.5 % |
| Q3 | Nov 12, 2025 | $-2.18 | $-1.42 | -53.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $182.00K | $215.41K | -15.5 % |
| Q1 | May 15, 2026 | $206.00K | $363.19K | -43.3 % |
| Q4 | Mar 27, 2026 | $256.00K | $142.91K | 79.1 % |
| Q3 | Nov 12, 2025 | $98.00K | $190.00K | -48.4 % |